483 Amgen Jan 2012

483 Amgen Jan 2012

Erika Butler FDA, Kimberley Hoefen FDA$119.00 - Available Now

FDA investigators audited the Amgen - Longmont, CO, United States facility and issued inspectional observations (via FDA 483) on 06 Jan 2012.

Product details

  • Category: Human Drugs
  • Inspection end: 06 Jan 2012
  • Location: Longmont, United States
  • FEI: 3002892484
Add To Cart